Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: A randomized placebo-controlled trial

Journal of Medical Virology

Volumn 81, Issue 5, 2009, Pages 908-914

  Cools, Herman J M ^a   Gussekloo, Jacobijn ^a   Remmerswaal, Joyce E M ^a   Remarque, Ed J ^b   Kroes, Aloys C M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Human; Influenza; Influenza vaccines; Long term care facilities; Vaccination dose

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; PLACEBO;

AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SEROLOGY;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION, SECONDARY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LONG-TERM CARE; MALE; TREATMENT OUTCOME; VACCINATION; VACCINES, INACTIVATED;

EID: 65649143828     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21456     Document Type: Article

References (29)

1. Arden NH, Patriarca PA, Lui KJ, Harmon MW, Brandon F, Kendal AP. 1986. Safety and immunogenicity of a 45-Mu-G supplemental dose of inactivated split-virus influenza-B vaccine in the elderly. J Infect Dis 153:805-806.
2. Atashili J, Kalilani L, Adimora AA. 2006. Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: A meta-analysis. BMC Infect Dis 6:138. (Pubitemid 44446728)
3. Beyer WEP, Palache AM, Baljet M, Masurel N. 1989. Antibody induction by influenza vaccines in the elderly - A review of the literature. Vaccine 7:385-394.
4. Beyer WEP, Palache AM, Lüchters G, Nauta J, Osterhaus ADME. 2004. Seroprotection rate, mean fold increase, seroconversion rate: Which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 103:125-132.
5. Couch RB, Winokur P, Brady R, Belshe R, Chen WH, Cate TR, Sigurdardottir B, Hoeper A, Graham IL, Edelman R, He F, Nino D, Capellan J, Ruben FL. 2007. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 25:7656-7663.
6. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ, Walter Reed Health Care System Influenza Vaccine Consortium. 2008. Half-versus full-dose trivalent inactivated influenza vaccine (2004-2005): Age, dose, and sex effects on immune responses. Arch Intern Med 168:2405-2414.
7. Gaughran F, Walwyn R, Lambkin-Williams R, Whelan P, Chatterton K, Oxford J, Macdonald A. 2007. Flu-Effect of Vaccine in Elderly Residents Trial Team. Flu-effect of vaccine in elderly care home residents: A randomized trial. J Am Geriatr Soc 55:1912-1920.
8. Glezen WP, Keitel WA, Taber LH, Piedra PA, Clover RD, Couch RB. 1991. Age distribution of patients with medically attended illnesses caused by sequential variants of influenza A/H1N1 - Comparison to age-specific infection-rates, 1978-1989. Am J Epidemiol 133:296-304.
9. Gooskens J, Swaan CM, Claas ECJ, Kroes ACM. 2007. Rapid molecular detection of influenza outbreaks in nursing homes. J Clin Virol 41:7-12.
10. Gross PA, Quinnan GV, Weksler ME, Gaerlan PF, Denning CR. 1988. Immunization of elderly people with high doses of Influenza vaccine. J Am Geriatr Soc 36:209-212.
11. Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, Murad S, Watson JM. 2006. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: Cluster randomised controlled trial. Br Med J 333:1241-1246.
12. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demichelli V. 2005. Efficacy and effectiveness of influenza vaccines in elderly people: A systematic review. Lancet 366:1165-1174.
13. Katz S, Downs TD, Cash HR, Grotz RC. 1970. Progress in the development of the index of ADL. Gerontologist 10:20-30.
14. Keitel WA, Atmar RL, Cate TR, Peterson NJ, Greenberg SB, Ruben F, Couch RB. 2006. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 166:1121-1127.
15. Kelly H, Attia J, Andrews R, Heller FR. 2004. The number needed to vaccinate (NNV) and population extensions of the NNV: Comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over. Vaccine 22:2192-2198.
16. Looijmans-van den Akker I, Delden JJM, van, Hak E. 2007. Uptake of influenza vaccination in Dutch nursing home personnel following national recommendations. J Am Geriatr Soc 55:1486-1487.
17. Meyer WJ, Wood JM, Major D, Robertson JS, Webster RG, Katz JM. 1993. Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses. Virology 196:130-137.
18. Moscona A. 2005. Neuraminidase inhibitors for influenza. N Engl J Med 353:1363-1373.
19. Nichol KL, Nordin JD, Nelson DB, Mulloly JP, Hak E. 2007. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357:1373-1381.
20. Palache AM, Beyer WEP, Lüchters G, Völker R, Sprenger MJW, Masurel N. 1993. Influenza vaccines: The effect of vaccine dose on antibody response in primed populations during the ongoing inter-pandemic period. A review of the literature. Vaccine 11:892-908. (Pubitemid 43336030)
21. Palache AM, Beyer WE, Sprenger MJ, Masurel N, de Jonge S, Vardy A, Charpentier B, Noury J, van Beek WC, Borst RJ. 1993. Antibody-response after Influenza immunization with various vaccine doses - A double-blind, placebo-controlled, multi-center, dose-response study in elderly nursing-home residents and young volunteers. Vaccine 11:3-9. (Pubitemid 23080723)
22. Palmer DF, Dowdle WR, Coleman MT, Schild GC. 1975. Haemagglutination inhibition test. In: Advanced laboratory techniques for influenza diagnosis. Procedural guide. Atlanta, USA: Department of Health and Welfare. pp 25-62.
23. Peters NL, Meiklejohn G, Jahnigen DW. 1988. Antibody-response of an elderly population to a supplemental dose of Influenza-B vaccine. J Am Geriatr Soc 36:593-599.
24. Pyhälä R, Pyhälä L, Valle M, Aho K. 1987. Egg-grown and tissue-culture-grown variants of influenza A (H3N2) virus with special attention to their use as antigens in seroepidemiology. Epidemiol Infect 99:745-753.
25. Remarque EJ, van Beek WC, Ligthart GJ, Borst RJ, Nagelkerken L, Palache AM, Sprenger MJ, Masurel N. 1993. Improvement of the Immunoglobulin subclass response to Influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine 11:649-654.
26. Remarque EJ, de Jong JMA, van der Klis RJ, Masurel N, Lighthart GJ. 1999. Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients. Exp Gerontol 34:109-115.
27. Roos-van Eijndhoven DG, Cools HJM, Westendorp RGJ, Cate-Hoek AJ, Knook DL, Remarque EJ. 2001. Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in elderly subjects. J Med Virol 63:293-298.
28. Sullivan KM, Monto AS, Foster DA. 1990. Antibody response to inactivated Influenza vaccines of various antigenic concentrations. J Infect Dis 161:333-335.
29. Van der Sande MAB, Ruijs WLM, Meijer A, Cools HJM, van der Plas SM. 2006. Use of oseltamivir in Dutch nursing homes during the 2004-2005 influenza season. Vaccine 24:6664-6669.